LADX

LadRx Corp
—

Company Information

Company Name
LadRx Corp
CIK
CIK0000799698
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
LADX: OTC
Fiscal Year End
December 31
Owner Organization
03 Life Sciences
SIC
2836
SIC Description
Biological Products, (No Diagnostic Substances)
Ticker
LADX

SEC filing data through

Insider Sentiment

Last purchase
2013-12-10
Last sale
—
Shares purchased (TTM)
459,633
Shares sold (TTM)
0
Buy ratio (TTM)100.0%

Institutional Sentiment

As of
2025-06-30
Institutional shares owned
1
Shares outstanding
495,092
Ownership
0.00%
0.00% Y/Y

Earnings Market Reaction

Filing date
2025-05-14
Price on filing date
—
1-month reaction
2.38%
3-month reaction
-36.31%
Drift continued1/10 (10%)
Faded / reversed9/10 (90%)

Balance Sheet

Values in millions ($)
Line item2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets Current
Cash And Cash Equivalents At Carrying Value010122341134
Insurance Settlements Receivable Current-----------0
Prepaid Expense And Other Assets Current000000000100
Assets Current010122341235
Property Plant And Equipment Net000000000000
Other Assets Noncurrent000000000000
Operating Lease Right Of Use Asset-----0000000
Assets010122341235
Liabilities Current
Accounts Payable Current111111111111
Accounts Payable And Other Accrued Liabilities Current111111111111
Operating Lease Liability Current-----0000000
Liabilities Current222222222223
Operating Lease Liability Noncurrent---------000
Temporary Equity Carrying Amount Attributable To Parent--------1111
Stockholders Equity
Liabilities-----22--2--
Common Stock Value000000000000
Additional Paid In Capital489489489489489489489489488488487487
Retained Earnings Accumulated Deficit-491-490-490-490-488-489-488-487-490-489-488-487
Stockholders Equity-2-1-2-10012-2-1-01
Liabilities And Stockholders Equity010122341235
Preferred Stock Dividend Rate Percentage--------00--
Temporary Equity Par Or Stated Value Per Share-------1,000.001,000.001,000.001,000.001,000.00
Temporary Equity Shares Outstanding-------00000
Temporary Equity Shares Issued-------00000
Preferred Stock Par Or Stated Value Per Share0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized111111111111
Preferred Stock Shares Issued0000000--0--
Preferred Stock Shares Outstanding0000000--0--
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized626262626262626262626262
Common Stock Shares Issued000000000000
Shares Outstanding000000000000

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

LadRx Corp (LADX) — SEC Financial Statements & Analysis

LadRx Corp (LADX) is a biological products, (no diagnostic substances) company, incorporated in DE. LadRx Corp trades on OTC as: LADX. LadRx Corp (LADX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-14. Based on that filing, LadRx Corp carries a market cap of $802.05K, a P/E ratio of -0.32x, a P/B ratio of -0.38x, an enterprise value of $595.10K, and an EV/EBITDA multiple of -0.17x. On profitability, it posts a Return on Equity (ROE) of 278.92% and a Return on Assets (ROA) of -201.16%. Per share, it reports EPS of $-5.04, diluted EPS of $-5.04, free cash flow per share of $-3.75, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -244.22% year-over-year and EPS growth of -244.22% year-over-year. On the balance sheet, it maintains a current ratio of 0.11x, a quick ratio of 0.09x, working capital of $-2.14M, a debt-to-equity ratio of -1.12x, a debt ratio of 9.21, free cash flow of $-1.86M (TTM), and net debt of $-206.95K. Figures sourced from SEC EDGAR.

Market Cap
$802.05K
P/E TTM
-0.32x
EPS TTM
$-5.04
P/B TTM
-0.38x
ROE TTM
278.92%
ROA TTM
-201.16%
Debt To Equity
-1.12x
Free Cash Flow TTM
$-1.86M

Data as of 2025-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LadRx Corp in?

LadRx Corp (LADX) operates in the Biological Products, (No Diagnostic Substances) industry.

What exchange does LADX trade on?

LadRx Corp (LADX) trades on the OTC.

Where is LadRx Corp incorporated?

LadRx Corp is incorporated in DE.

When was LadRx Corp (LADX)'s most recent SEC filing?

LadRx Corp (LADX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-14.

What is LADX's market cap?

LadRx Corp (LADX) has a market capitalization of $802.05K as of 2025-03-31.

What is LADX's EPS (earnings per share)?

LadRx Corp (LADX)'s trailing twelve month EPS is $-5.04 as of 2025-03-31.

What is LADX's ROE (return on equity)?

LadRx Corp (LADX)'s trailing twelve month Return on Equity (ROE) is 278.92% as of 2025-03-31.

What is LADX's ROA (return on assets)?

LadRx Corp (LADX)'s trailing twelve month Return on Assets (ROA) is -201.16% as of 2025-03-31.

What is LADX's EV/EBITDA?

LadRx Corp (LADX)'s trailing twelve month EV/EBITDA is -0.17x as of 2025-03-31.

Wall Street's data.
Main Street's price.